Clinical Investigations of the Contraceptive and Therapeutic Potential of Nafarelin
book-chapter
OA: closed
CC0
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
The paper presents clinical investigations evaluating the contraceptive and therapeutic potential of nafarelin, without providing an abstract or specific findings in the provided text.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (2)
References (22)
- COMPARISON OF CELLULAR LEVELS OF STEROID RECEPTORS IN UTERINE LEIOMYOMA AND MYOMETRIUM via openalex
- Treatment of endometriosis with a potent agonist of gonadotropin-releasing hormone (nafarelin) via openalex
- W1971343838 via openalex
- W1978860276 via openalex
- W1980806708 via openalex
- W2006494659 via openalex
- W2022690114 via openalex
- W2044603843 via openalex
- W2044970382 via openalex
- W2055279641 via openalex
- W2067101889 via openalex
- W2068758998 via openalex
- W2075860102 via openalex
- W2275981118 via openalex
- W2295442428 via openalex
- W2336790305 via openalex
- W2408619637 via openalex
- W2410955081 via openalex
- W2418304981 via openalex
- W140454929 via openalex
- W4295690069 via openalex
- W155633977 via openalex
Source provenance
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- unpaywall
- last seen: 2026-09-24T06:17:16.569905+00:00
License: CC0
· commercial use OK